Please use a PC Browser to access Register-Tadawul
Get It
Behind the Scenes of Johnson & Johnson's Latest Options Trends
Johnson & Johnson +0.32%
Johnson & Johnson JNJ | 240.40 | +0.32% |
Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE:JNJ) revealed 15 unusual trades.
Delving into the details, we found 26% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $387,598, and 10 were calls, valued at $442,660.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $185.0 to $250.0 for Johnson & Johnson over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale trades within a strike price range from $185.0 to $250.0 in the last 30 days.
Johnson & Johnson Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | PUT | TRADE | NEUTRAL | 01/15/27 | $12.35 | $9.55 | $11.0 | $220.00 | $188.1K | 965 | 0 |
| JNJ | CALL | TRADE | NEUTRAL | 02/20/26 | $59.15 | $56.1 | $57.34 | $185.00 | $86.0K | 329 | 16 |
| JNJ | PUT | SWEEP | BEARISH | 07/17/26 | $12.75 | $11.7 | $12.75 | $240.00 | $82.8K | 607 | 82 |
| JNJ | CALL | SWEEP | BULLISH | 02/20/26 | $53.0 | $51.1 | $53.0 | $190.00 | $79.5K | 438 | 16 |
| JNJ | CALL | TRADE | NEUTRAL | 07/17/26 | $57.35 | $54.05 | $55.88 | $190.00 | $55.8K | 1.8K | 0 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Present Market Standing of Johnson & Johnson
- With a trading volume of 3,262,455, the price of JNJ is down by -0.48%, reaching $242.29.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 56 days from now.
Professional Analyst Ratings for Johnson & Johnson
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $231.6.
- An analyst from B of A Securities has decided to maintain their Neutral rating on Johnson & Johnson, which currently sits at a price target of $221.
- An analyst from Freedom Capital Markets has decided to maintain their Hold rating on Johnson & Johnson, which currently sits at a price target of $220.
- Showing optimism, an analyst from Morgan Stanley upgrades its rating to Overweight with a revised price target of $262.
- Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Johnson & Johnson, targeting a price of $255.
- Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Johnson & Johnson, targeting a price of $200.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
